Efficacy of naxitamab in patients with refractory/relapse (R/R) high-risk neuroblastoma (HR-NB) by bone/bone marrow (BM) evaluation, potential sites of residual disease Meeting Abstract
| Authors: | Kushner, B. H.; Morgenstern, D. A.; Nysom, K.; Bear, M. K.; Tornoe, K.; Losic, N.; Mora, J. |
| Abstract Title: | Efficacy of naxitamab in patients with refractory/relapse (R/R) high-risk neuroblastoma (HR-NB) by bone/bone marrow (BM) evaluation, potential sites of residual disease |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120605209 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.10022 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10022 -- Source: Wos |
